Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300062
- Awardee
-
New England Biolabs, Inc. UEI EDKJNT8DADG8
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $9,522
Award facts
- Contract value 100% obligated
- $9,522.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Ipswich, MA 01938, USA
Award details come from SAM.gov/FPDS.
About this award
New England Biolabs, Inc. received a Blanket Purchase Agreement (BPA) call order awarded on January 8, 2014, with a ceiling value of $9,522.00 for the procurement of drugs and biologicals. The contract utilizes a firm fixed price structure and does not include a set-aside designation. Performance will be executed at the contractor's facility in Ipswich, Massachusetts. The funding originates from a civilian federal agency under the Office of the Director. As a leading manufacturer of molecular biology products, New England Biolabs specializes in providing reagents, kits, and enzymes essential for life sciences research, including next-generation sequencing technologies and genomics applications.
This BPA call order supports the federal government's biomedical research initiatives, particularly within the National Institutes of Health ecosystem. New England Biolabs has established a significant presence across multiple NIH institutes and centers, including the National Institute of Allergy and Infectious Diseases, National Human Genome Research Institute, and the Centers for Disease Control and Prevention. The company's product portfolio under federal contracts includes NEBNext library preparation kits, RNA and DNA sequencing reagents, PCR reagents, and various enzymatic kits that enable critical research in infectious disease investigation, genomics, and other advanced biomedical studies.
Quick answers
Who was awarded contract HHSN26300062?
HHSN26300062 was awarded to New England Biolabs, Inc. by Office of the Director (National Institutes of Health) on January 8, 2014.
How much is contract HHSN26300062 worth?
The government has obligated $9,522 on HHSN26300062.
Is contract HHSN26300062 an order under another contract?
Yes. HHSN26300062 is a BPA call under HHSN263201100018B, a blanket purchase agreement.
Was contract HHSN26300062 competed?
The extent of competition for HHSN26300062 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award